Gefitinib

Gefitinib is a targeted therapy medication used to treat non-small cell lung cancer (NSCLC) in patients with a specific genetic mutation. It works by blocking the growth and spread of cancer cells.

Uses: Gefitinib is primarily used to treat:

• Non-small cell lung cancer (NSCLC) in patients with a specific genetic mutation (EGFR mutation)

Important Considerations (Prescription Required):

1. Genetic Testing: Before starting Gefitinib treatment, genetic testing is necessary to determine if the patient has the EGFR mutation.
2. Regular Monitoring: During treatment, regular monitoring is required to assess for side effects and adjust the dosage as needed.
3. Medication Interactions: Gefitinib may interact with other medications. Inform your doctor about all prescription and over-the-counter drugs you are taking.